The admission appeared in a newly unredacted filing in the landmark copyright infringement legal battle playing out between newspapers like the Orlando Sentinel and tech companies Microsoft and OpenAI...

“It's making me dumber for sure.”

Anthropic’s survey of 80,000 Claude users provides detailed snapshot of how people are using technology

Ruslan Medzhitov shares his thoughts on the balance between generating data and developing theories in immunology, with a focus on exploring the rules that govern complex systems.

As federal research funding shrinks, scientists are looking to other sources of support. Can they learn to sell their work without selling out?

It’s still easy to get Grok to edit photographs of real people into sexualized poses, despite X’s updated restrictions.

Key PointsTrue functional high-risk MM is very uncommon when comprehensive clinical and molecular profiling is applied.High-risk GEP with standard-risk gen

When the people making AI seem trustworthy are the ones who trust it the least, it shows that incentives for speed are overtaking safety, experts say

Daratumumab, bortezomib, thalidomide, and dexamethasone (Dara-VTd) is the current standard of care in Europe based on the CASSIOPEIA study, which demonstrated improved depth of response and progressio...

An intensive international study was coordinated by the European Broadcasting Union (EBU) and led by the BBC

The internationally renowned expert in the calculation and communication of risk and statistics, Sir David Spiegelhalter, discusses the concept of a ‘preference zone’ to frame the demands of safety, e...

The much-needed modernization of the U.S. Army's battlefield communications network being undertaken by Anduril, Palantir and others is rife with "fundamental security" problems and vulnerabilities, and should be treated as a "very high risk," according to a recent internal Army memo.

Blood Cancer Journal - Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy

Larger, longer-lived species are expected to have a higher cancer prevalence compared to smaller, shorter-lived species owing to the greater number...

The BSH Guidelines Official Podcast · Episode

The situation is dire, but there are glimmers of hope

BYD has not announced plans to sell the Shark in the U.S., but it has entered countries such as Mexico, where GM, Ford and Toyota sell pickup trucks.